A Stable Irinotecan Liposome with Enhanced Antitumor Activity in a Range of Tumor Models

ConclusionsOverall, the CPT-11 liposome may be developed as a new clinical alternative for the cancer patients.
Source: Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research